Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Alteration"
Filter
Filter
Article category
Keywords
Publication year
Randomized Controlled Trial
A split face study on the effect of an anti-acne product containing fermentation products of Enterococcus faecalis CBT SL-5 on skin microbiome modification and acne improvement
Hye Sung Han , Sun Hye Shin , Bo-Yun Choi , Nayeon Koo , Sanghyun Lim , Dooheon Son , Myung Jun Chung , Kui Young Park , Woo Jun Sul
J. Microbiol. 2022;60(5):488-495.   Published online March 14, 2022
DOI: https://doi.org/10.1007/s12275-022-1520-6
  • 59 View
  • 0 Download
  • 10 Web of Science
  • 5 Crossref
AbstractAbstract
Antibiotic-resistant Cutibacterium acnes and dysbiosis of the skin microbiome are of increasing concern in acne treatment. Enterococcus faecalis, a widely used probiotic, has shown benefits for acne treatment by exerting antimicrobial activity against C. acnes. Therefore, this study aimed to investigate the efficacy and safety of an E. faecalis CBT SL-5-extract-containing lotion in patients with mild-to-moderate acne. Twenty patients were enrolled in this randomized, placebo-controlled, split-face comparative study. Patients were treated with E. faecalis lotion on one side of the face and a vehicle lotion on the other side for 4 weeks. The efficacy outcome measures included improvement in the investigators’ assessment of acne severity, patient satisfaction, changes in skin parameters and diversity of the skin microbiome. The investigators’ assessment score was significantly improved on the test side compared to the control side, after 2 weeks (p = 0.009) and 6 weeks (p < 0.0005). However, TEWL and skin hydration were not significantly different between the two groups. The phylogenetic diversity of the skin microbiota decreased over time in the skin samples of test side. In conclusion, E. faecalis CBT SL-5 extract can be a feasible and well-tolerated option for improving acne severity and skin microbiome dysbiosis in mild-to-moderate acne patients.

Citations

Citations to this article as recorded by  
  • Efficacy of a Postbiotic Formulation Combined With Microneedling for Mild‐to‐Moderate Acne: A Self‐Control Study
    Zhanhong Li, Peihui Li, Yu Xu, Changqing Yan, Xiufen Ma, Huiying Wang, Hong Cheng, Jing Zeng, Ting Li, Xinxian Li, Jia Zhou, Jie Zhang, Jianfeng Zhou, Rongya Yang, Yan Wu, Li Li, Wei Lai, Jiangyun Zhao, Zhe Liu, Qiong Meng
    Journal of Cosmetic Dermatology.2024;[Epub]     CrossRef
  • Using probiotics to treat acne vulgaris: systematic review
    Aleena Boby, Grace Lee, Nicole Natarelli, Lilia Correa
    Archives of Dermatological Research.2024;[Epub]     CrossRef
  • Skin Deep: The Potential of Microbiome Cosmetics
    Ju Hee Han, Hei Sung Kim
    Journal of Microbiology.2024; 62(3): 181.     CrossRef
  • The updates and implications of cutaneous microbiota in acne
    Cong Huang, Fan Zhuo, Baoquan Han, Wenting Li, Bin Jiang, Kaoyuan Zhang, Xingling Jian, Zhenzhen Chen, Hui Li, Haiyan Huang, Xia Dou, Bo Yu
    Cell & Bioscience.2023;[Epub]     CrossRef
  • Cutibacterium acnes Dysbiosis: Alternative Therapeutics for Clinical Application
    Sara Sá, Ruben Fernandes, Álvaro Gestoso, José Mário Macedo, Daniela Martins-Mendes, Ana Cláudia Pereira, Pilar Baylina
    Applied Sciences.2023; 13(21): 12086.     CrossRef
Review
REVIEW] The development of fluconazole resistance in Candida albicans – an example of microevolution of a fungal pathogen
Joachim Morschhäuser
J. Microbiol. 2016;54(3):192-201.   Published online February 27, 2016
DOI: https://doi.org/10.1007/s12275-016-5628-4
  • 51 View
  • 0 Download
  • 81 Crossref
AbstractAbstract
The yeast Candida albicans is a member of the microbiota in the gastrointestinal and urogenital tracts of most healthy persons, but it can also cause symptomatic infections, especially in immunocompromised patients. During the life-long association with its human host, C. albicans generates genetically altered variants that are better adapted to changes in their environment. A prime example of this microevolution is the development of resistance to the commonly used drug fluconazole, which inhibits ergosterol biosynthesis, during antimycotic therapy. Fluconazole resistance can be caused by mutations in the drug target, by changes in the sterol biosynthesis pathway, and by gain-of-function mutations in transcription factors that result in the constitutive upregulation of ergosterol biosynthesis genes and multidrug efflux pumps. Fluconazole also induces genomic rearrangements that result in gene amplification and loss of heterozygosity for resistance mutations, which further increases drug resistance. These genome alterations may affect extended chromosomal regions and have additional phenotypic consequences. A striking case is the loss of heterozygosity for the mating type locus MTL in many fluconazole-resistant clinical isolates, which allows the cells to switch to the mating-competent opaque phenotype. This, in turn, raises the possibility that sexual recombination between different variants of an originally clonal, drug-susceptible population may contribute to the generation of highly fluconazole-resistant strains with multiple resistance mechanisms. The gain-of-function mutations in transcription factors, which result in deregulated gene expression, also cause reduced fitness. In spite of this, many clinical isolates that contain such mutations do not exhibit fitness defects, indicating that they have overcome the costs of drug resistance with further evolution by still unknown mechanisms.

Citations

Citations to this article as recorded by  
  • Structural, physicochemical characterization and antimicrobial activities of a new tris(8-quinolinolato-κ2N,O)cobalt(III) ethanol solvate [Co(C9H6NO)3].(C2H6O)
    Salsabil Idoudi, Badiaa Essghaier, Mohamed Faouzi Zid, Saoussen Namouchi Cherni
    Journal of Molecular Structure.2024; 1296: 136848.     CrossRef
  • Adaptation of Candida albicans to specific host environments by gain-of-function mutations in transcription factors
    Joachim Morschhäuser, Aaron P. Mitchell
    PLOS Pathogens.2024; 20(11): e1012643.     CrossRef
  • The Neosartorya (Aspergillus) fischeri antifungal protein NFAP2 has low potential to trigger resistance development in Candida albicans in vitro
    Gábor Bende, Nóra Zsindely, Krisztián Laczi, Zsolt Kristóffy, Csaba Papp, Attila Farkas, Liliána Tóth, Szabolcs Sáringer, László Bodai, Gábor Rákhely, Florentine Marx, László Galgóczy, Gustavo H. Goldman, Norman van Rhijn
    Microbiology Spectrum.2024;[Epub]     CrossRef
  • Tackling multi-drug resistant fungi by efflux pump inhibitors
    Kritika Engle, Gautam Kumar
    Biochemical Pharmacology.2024; 226: 116400.     CrossRef
  • The TAC1 Gene in Candida albicans: Structure, Function, and Role in Azole Resistance: A Mini-Review
    Amir Hossein Mahdizade, Akbar Hoseinnejad, Mona Ghazanfari, Mohammad Javad Boozhmehrani, Seyed Sobhan Bahreiny, Mahdi Abastabar, Roberta Galbo, Letterio Giuffrè, Iman Haghani, Orazio Romeo
    Microbial Drug Resistance.2024; 30(7): 288.     CrossRef
  • Boric Acid for the Treatment of Vaginitis: New Possibilities Using an Old Anti‐Infective Agent: A Systematic Review
    Matilde Lærkeholm Müller, Christina Damsted Petersen, Ditte Marie L. Saunte, Althea East-Innis
    Dermatologic Therapy.2024;[Epub]     CrossRef
  • Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis
    Jyoti Sankar Prusty, Ashwini Kumar, Awanish Kumar
    Critical Reviews in Microbiology.2024; : 1.     CrossRef
  • Microevolution during Chronic Infection May Lead T. asahii to Coexist with the Host
    Gen Ba, Xuelian Lv, Xin Yang, Wenling Wang, Junhong Ao, Rongya Yang, Ioannis D. Bassukas
    Dermatology Research and Practice.2024;[Epub]     CrossRef
  • Cluster analysis allowed to identify antifungal drugs that retain efficacy against Candida albicans isolated from patients with inflammatory diseases of the soft tissues of the maxillofacial area
    Mariia Faustova, Volodymyr Dobrovolskyi, Galina Loban’, Yevhenii Bereza, Aleksandra Kotelnikova, Oleksandr Dobrovolskyi
    Frontiers in Oral Health.2024;[Epub]     CrossRef
  • Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae
    Tsuyoshi Yamada, Mari Maeda, Hiroaki Nagai, Karine Salamin, Yun-Tsan Chang, Emmanuella Guenova, Marc Feuermann, Michel Monod, Andreas H. Groll
    Antimicrobial Agents and Chemotherapy.2023;[Epub]     CrossRef
  • Anticandidal activity of nanocomposite based on nanochitosan, nanostarch and mycosynthesized copper oxide nanoparticles against multidrug-resistant Candida
    Mohamed Saied, Mohamed Hasanin, Tarek M. Abdelghany, Basma H. Amin, Amr H. Hashem
    International Journal of Biological Macromolecules.2023; 242: 124709.     CrossRef
  • Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone®) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection
    Vinicius Alves, Pedro Henrique Martins, Bruna Miranda, Iara Bastos de Andrade, Luiza Pereira, Christina Takiya Maeda, Glauber Ribeiro de Sousa Araújo, Susana Frases
    Journal of Fungi.2023; 9(8): 783.     CrossRef
  • Detrimental consequences of tebuconazole on redox homeostasis and fatty acid profile of honeybee brain
    Máté Mackei, Csilla Sebők, Júlia Vöröházi, Patrik Tráj, Fruzsina Mackei, Barnabás Oláh, Hedvig Fébel, Zsuzsanna Neogrády, Gábor Mátis
    Insect Biochemistry and Molecular Biology.2023; 159: 103990.     CrossRef
  • Benzamidine Conjugation Converts Expelled Potential Active Agents into Antifungals against Drug-Resistant Fungi
    Xue Wang, Xueyang Jin, Zhiyu Xie, Hongyang Zhang, Tiantian Liu, Hongbo Zheng, Xiaoyi Luan, Yan Sun, Wenjie Fang, Wenqiang Chang, Hongxiang Lou
    Journal of Medicinal Chemistry.2023; 66(19): 13684.     CrossRef
  • Advances in efficacy enhancement of photosensitizer-mediated photodynamic antimicrobial chemotherapy
    Benard M. Isaiah, Edith K. Amuhaya, Clare I. Muhanji
    Journal of Porphyrins and Phthalocyanines.2023; 27(06): 819.     CrossRef
  • Azobenzene derivatives with activity against drug‐resistant Candida albicans and Candida auris
    Martina Raschig, Bernardo Ramírez‐Zavala, Johannes Wiest, Marco Saedtler, Marcus Gutmann, Ulrike Holzgrabe, Joachim Morschhäuser, Lorenz Meinel
    Archiv der Pharmazie.2023;[Epub]     CrossRef
  • A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans
    Arome Solomon Odiba, Olanrewaju Ayodeji Durojaye, Ifeoma Maureen Ezeonu, Anthony Christian Mgbeahuruike, Bennett Chima Nwanguma
    Infection and Drug Resistance.2022; Volume 15: 3111.     CrossRef
  • Metabolite profiling, antifungal, biofilm formation prevention and disruption of mature biofilm activities of Erythrina senegalensis stem bark extract against Candida albicans and Candida glabrata
    Benjamin Kingsley Harley, Anthony Martin Quagraine, David Neglo, Mike Okweesi Aggrey, Emmanuel Orman, Nana Ama Mireku-Gyimah, Cedric Dzidzor Amengor, Jonathan Jato, Yussif Saaka, Theophilus Christian Fleischer, Umakanta Sarker
    PLOS ONE.2022; 17(11): e0278096.     CrossRef
  • Antifungal Exposure and Resistance Development: Defining Minimal Selective Antifungal Concentrations and Testing Methodologies
    Emily M. Stevenson, William H. Gaze, Neil A. R. Gow, Alwyn Hart, Wiebke Schmidt, Jane Usher, Adilia Warris, Helen Wilkinson, Aimee K. Murray
    Frontiers in Fungal Biology.2022;[Epub]     CrossRef
  • The Risk Factors and Mechanisms of Azole Resistance of Candida tropicalis Blood Isolates in Thailand: A Retrospective Cohort Study
    Teera Leepattarakit, Orawan Tulyaprawat, Popchai Ngamskulrungroj
    Journal of Fungi.2022; 8(10): 983.     CrossRef
  • Genomic Variation-Mediating Fluconazole Resistance in Yeast
    Wen-Yao Wang, Hong-Qing Cai, Si-Yuan Qu, Wei-Hao Lin, Cheng-Cheng Liang, Hao Liu, Ze-Xiong Xie, Ying-Jin Yuan
    Biomolecules.2022; 12(6): 845.     CrossRef
  • Antifungals and Drug Resistance
    Chowdhury Mobaswar Hossain, Lisa Kathleen Ryan, Meeta Gera, Sabyasachi Choudhuri, Nazmun Lyle, Kazi Asraf Ali, Gill Diamond
    Encyclopedia.2022; 2(4): 1722.     CrossRef
  • Synergistic Effect of the Combination of Deferoxamine and Fluconazole In Vitro and In Vivo against Fluconazole-Resistant Candida Spp.
    Lulu An, Jingwen Tan, Yuanyuan Wang, Siyu Liu, Yongyong Li, Lianjuan Yang
    Antimicrobial Agents and Chemotherapy.2022;[Epub]     CrossRef
  • Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of Candidiasis
    Wuqiang Wen, Hongxuan Cao, Yunyuan Huang, Jie Tu, Chen Wan, Jian Wan, Xinya Han, Han Chen, Jiaqi Liu, Li Rao, Chen Su, Chao Peng, Chunquan Sheng, Yanliang Ren
    Journal of Medicinal Chemistry.2022; 65(3): 2656.     CrossRef
  • Genome plasticity in Candida albicans: A cutting-edge strategy for evolution, adaptation, and survival
    Ifeanyi Elibe Mba, Emeka Innocent Nweze, Emmanuel Aniebonam Eze, Zikora Kizito Glory Anyaegbunam
    Infection, Genetics and Evolution.2022; 99: 105256.     CrossRef
  • Activity of poly(methacrylic acid)-silver nanoparticles on fluconazole-resistant Candida albicans strains: Synergistic and cytotoxic effects
    Cecília Maria Cruz Falcão, Audrey Andrade, Vanderlan Nogueira Holanda, Regina Celia Bressan Queiroz de Figueiredo, Eulália Azevedo Ximenes, Anderson Stevens Leonidas Gomes
    Journal of Applied Microbiology.2022; 132(6): 4300.     CrossRef
  • Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies
    Raphaëlle Youf, Max Müller, Ali Balasini, Franck Thétiot, Mareike Müller, Alizé Hascoët, Ulrich Jonas, Holger Schönherr, Gilles Lemercier, Tristan Montier, Tony Le Gall
    Pharmaceutics.2021; 13(12): 1995.     CrossRef
  • Etoposide and Camptothecin Reduce Growth, Viability, the Generation of Petite Mutants, and Recognize the Active Site of DNA Topoisomerase I and II Enzymes in Candida glabrata
    Dulce Andrade-Pavón, Omar Gómez-García
    Indian Journal of Microbiology.2021; 61(3): 306.     CrossRef
  • 8-hydroxyquinoline-5-(N-4-chlorophenyl) sulfonamide and fluconazole combination as a preventive strategy for Candida biofilm in haemodialysis devices
    Letícia Fernandes da Rocha, Bruna Pippi, Angélica Rocha Joaquim, Saulo Fernandes de Andrade, Alexandre Meneghello Fuentefria
    Journal of Medical Microbiology .2021;[Epub]     CrossRef
  • Genetic diversity and molecular epidemiology of Candida albicans from vulvovaginal candidiasis patients
    Ji-yun Tian, Yong-gang Yang, Shi Chen, Yong Teng, Xin-zheng Li
    Infection, Genetics and Evolution.2021; 92: 104893.     CrossRef
  • Chronic recurrent vulvovaginitis is not only due to Candida
    Alicia Arechavala, Ricardo Negroni, Gabriela Santiso, Roxana Depardo, Pablo Bonvehí
    Revista Iberoamericana de Micología.2021; 38(3): 132.     CrossRef
  • Systematic truncations of chromosome 4 and their responses to antifungals in Candida albicans
    Wasim Uddin, Darshan Dhabalia, S.M. Udaya Prakash, M. Anaul Kabir
    Journal of Genetic Engineering and Biotechnology.2021; 19(1): 92.     CrossRef
  • Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration
    Xueyang Jin, Ming Zhang, Jinghui Lu, Ximeng Duan, Jinyao Chen, Yue Liu, Wenqiang Chang, Hongxiang Lou
    Journal of Advanced Research.2021; 34: 65.     CrossRef
  • Lysinibacillus Isolate MK212927: A Natural Producer of Allylamine Antifungal ‘Terbinafine’
    Sayed E. El-Sayed, Neveen A. Abdelaziz, Hosam-Eldin Hussein Osman, Ghadir S. El-Housseiny, Ahmed E. Aleissawy, Khaled M. Aboshanab
    Molecules.2021; 27(1): 201.     CrossRef
  • New Approach to Antifungal Activity of Fluconazole Incorporated into the Porous 6-Anhydro-α-l-Galacto-β-d-Galactan Structures Modified with Nanohydroxyapatite for Chronic-Wound Treatments—In Vitro Evaluation
    Justyna Rewak-Soroczynska, Paulina Sobierajska, Sara Targonska, Agata Piecuch, Lukasz Grosman, Jaroslaw Rachuna, Slawomir Wasik, Michal Arabski, Rafal Ogorek, Rafal J. Wiglusz
    International Journal of Molecular Sciences.2021; 22(6): 3112.     CrossRef
  • The phosphatome of opportunistic pathogen Candida species
    Krisztina Szabó, Márton Miskei, Ilona Farkas, Viktor Dombrádi
    Fungal Biology Reviews.2021; 35: 40.     CrossRef
  • Azole-triphenylphosphonium conjugates combat antifungal resistance and alleviate the development of drug-resistance
    Xin Wang, Jun Liu, Jinyao Chen, Ming Zhang, Chuan Tian, Xiaoping Peng, Gang Li, Wenqiang Chang, Hongxiang Lou
    Bioorganic Chemistry.2021; 110: 104771.     CrossRef
  • Activity of Compound Agrimony Enteritis Capsules against invasive candidiasis: Exploring the differences between traditional Chinese medicine prescriptions and its main components in the treatment of diseases
    Jun Li, Ze-Hua Jin, Jia-Sheng Li, Liu-Yan Su, Ying-Xian Wang, Yi Zhang, Ding-Mei Qin, Gao-Xiong Rao, Rui-Rui Wang
    Journal of Ethnopharmacology.2021; 277: 114201.     CrossRef
  • Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans
    Eric Delarze, Ludivine Brandt, Emilie Trachsel, Marion Patxot, Claire Pralong, Fabio Maranzano, Murielle Chauvel, Mélanie Legrand, Sadri Znaidi, Marie-Elisabeth Bougnoux, Christophe d’Enfert, Dominique Sanglard
    Frontiers in Microbiology.2020;[Epub]     CrossRef
  • A Zinc Cluster Transcription Factor Contributes to the Intrinsic Fluconazole Resistance of Candida auris
    Eva-Maria Mayr, Bernardo Ramírez-Zavala, Ines Krüger, Joachim Morschhäuser, Aaron P. Mitchell
    mSphere.2020;[Epub]     CrossRef
  • Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design
    Brian C. Monk, Alia A. Sagatova, Parham Hosseini, Yasmeen N. Ruma, Rajni K. Wilson, Mikhail V. Keniya
    Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2020; 1868(3): 140206.     CrossRef
  • Dispiropyrrolidine tethered piperidone heterocyclic hybrids with broad-spectrum antifungal activity against Candida albicans and Cryptococcus neoformans
    Sarah Lawson, Natarajan Arumugam, Abdulrahman I. Almansour, Raju Suresh Kumar, Shankar Thangamani
    Bioorganic Chemistry.2020; 100: 103865.     CrossRef
  • Lipid composition and cell surface hydrophobicity of Candida albicans influence the efficacy of fluconazole–gentamicin treatment
    Jakub Suchodolski, Jakub Muraszko, Aleksandra Korba, Przemysław Bernat, Anna Krasowska
    Yeast.2020; 37(1): 117.     CrossRef
  • Adaptive Laboratory Evolution of Native Torulaspora delbrueckii YCPUC10 With Enhanced Ethanol Resistance and Evaluation in Co-inoculated Fermentation
    Daniela Catrileo, Andrea Acuña-Fontecilla, Liliana Godoy
    Frontiers in Microbiology.2020;[Epub]     CrossRef
  • Genotype, biofilm formation ability and specific gene transcripts characteristics of endodontic Enterococcus faecalis under glucose deprivation condition
    Yawen Liu, Yifan Ping, Yuhua Xiong, Ruyu Zhou, Fulu Xu, Juan Wang, Jin Li
    Archives of Oral Biology.2020; 118: 104877.     CrossRef
  • Improved Methods of Extraction and In Vitro Evaluation of Antimicrobial Potential of Stem Bark of Terminalia arjuna
    Sarita Khatkar, Arun Nanda, Shahid Husain Ansari
    Current Biochemical Engineering.2019; 5(1): 50.     CrossRef
  • The small GTPase Rhb1 is involved in the cell response to fluconazole inCandida albicans
    Yu-Wen Chen, Ying-Chieh Yeh, Hsueh-Fen Chen, Ruei-Ching Chen, Guan-Yu Lin, Yu-Ting Chen, Chung-Yu Lan
    FEMS Yeast Research.2019;[Epub]     CrossRef
  • The Magnitude ofCandida albicansStress-Induced Genome Instability Results from an Interaction Between Ploidy and Antifungal Drugs
    Ognenka Avramovska, Meleah A Hickman
    G3 Genes|Genomes|Genetics.2019; 9(12): 4019.     CrossRef
  • Cytochalasans from the Endophytic Fungus Xylaria cf. curta with Resistance Reversal Activity against Fluconazole-Resistant Candida albicans
    Wen-Xuan Wang, Xinxiang Lei, Hong-Lian Ai, Xue Bai, Jing Li, Juan He, Zheng-Hui Li, Yong-Sheng Zheng, Tao Feng, Ji-Kai Liu
    Organic Letters.2019; 21(4): 1108.     CrossRef
  • Antifungal Activity of a Hydroethanolic Extract From Astronium urundeuva Leaves Against Candida albicans and Candida glabrata
    Bruna Vidal Bonifácio, Taissa Vieira Machado Vila, Isadora Fantacini Masiero, Patrícia Bento da Silva, Isabel Cristiane da Silva, Érica de Oliveira Lopes, Matheus Aparecido dos Santos Ramos, Leonardo Perez de Souza, Wagner Vilegas, Fernando Rogério Pavan,
    Frontiers in Microbiology.2019;[Epub]     CrossRef
  • Dissection of the regulatory role for the N-terminal domain in Candida albicans protein phosphatase Z1
    Krisztina Szabó, Zoltán Kónya, Ferenc Erdődi, Ilona Farkas, Viktor Dombrádi, Joy Sturtevant
    PLOS ONE.2019; 14(2): e0211426.     CrossRef
  • The Impact of Gene Dosage and Heterozygosity on the Diploid Pathobiont Candida albicans
    Shen-Huan Liang, Richard J. Bennett
    Journal of Fungi.2019; 6(1): 10.     CrossRef
  • Evolution of Fluconazole-Resistant Candida albicans Strains by Drug-Induced Mating Competence and Parasexual Recombination
    Christina Popp, Bernardo Ramírez-Zavala, Sonja Schwanfelder, Ines Krüger, Joachim Morschhäuser, Judith Berman
    mBio.2019;[Epub]     CrossRef
  • Accelerated evolution at chaperone promoters among Antarctic notothenioid fishes
    Samuel N. Bogan, Sean P. Place
    BMC Evolutionary Biology.2019;[Epub]     CrossRef
  • Elevation of cell wall chitin via Ca2+–calcineurin‐mediated PKC signaling pathway maintains the viability of Candida albicans in the absence of β‐1,6‐glucan synthesis
    Qi Han, Na Wang, Chaoying Pan, Yue Wang, Jianli Sang
    Molecular Microbiology.2019; 112(3): 960.     CrossRef
  • Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161
    Brian C. Monk, Mikhail V. Keniya, Manya Sabherwal, Rajni K. Wilson, Danyon O. Graham, Harith F. Hassan, Danni Chen, Joel D. A. Tyndall
    Antimicrobial Agents and Chemotherapy.2019;[Epub]     CrossRef
  • The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors
    Jingxiang Zhang, Liping Li, Quanzhen Lv, Lan Yan, Yan Wang, Yuanying Jiang
    Frontiers in Microbiology.2019;[Epub]     CrossRef
  • Two New 1,3,4-Oxadiazoles With Effective Antifungal Activity Against Candida albicans
    Isis Regina Grenier Capoci, Karina Mayumi Sakita, Daniella Renata Faria, Franciele Abigail Vilugron Rodrigues-Vendramini, Glaucia Sayuri Arita, Admilton Gonçalves de Oliveira, Maria Sueli Felipe, Bernard Maigret, Patricia de Souza Bonfim-Mendonça, Erika S
    Frontiers in Microbiology.2019;[Epub]     CrossRef
  • Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole
    J. Król, U. Nawrot, M. Bartoszewicz
    Journal de Mycologie Médicale.2018; 28(2): 327.     CrossRef
  • Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor
    Alexandra Carreira, João Boavida Ferreira, Iliana Pereira, João Ferreira, Paulo Filipe, Ricardo Boavida Ferreira, Sara Monteiro
    Journal of Medical Microbiology.2018; 67(2): 198.     CrossRef
  • Varying susceptibility of clinical and environmental Scedosporium isolates to chemical oxidative stress in conidial germination
    Cindy Staerck, Charlotte Godon, Jean-Philippe Bouchara, Maxime J. J. Fleury
    Archives of Microbiology.2018; 200(3): 517.     CrossRef
  • Rice Defensin OsAFP1 is a New Drug Candidate against Human Pathogenic Fungi
    Akihito Ochiai, Kodai Ogawa, Minami Fukuda, Masahiro Ohori, Takumi Kanaoka, Takaaki Tanaka, Masayuki Taniguchi, Yoshiyuki Sagehashi
    Scientific Reports.2018;[Epub]     CrossRef
  • Thiobarbiturates as potential antifungal agents to control human infections caused by Candida and Cryptococcus species
    Muhammad Shabeer, Luiz C. A. Barbosa, Milandip Karak, Amanda C. S. Coelho, Jacqueline A. Takahashi
    Medicinal Chemistry Research.2018; 27(4): 1043.     CrossRef
  • A Case for Antifungal Stewardship
    Rachel A. Miller
    Current Fungal Infection Reports.2018; 12(1): 33.     CrossRef
  • A Hyperactive Form of the Zinc Cluster Transcription Factor Stb5 Causes YOR1 Overexpression and Beauvericin Resistance in Candida albicans
    Bernardo Ramírez-Zavala, Hannah Manz, Frank Englert, P. David Rogers, Joachim Morschhäuser
    Antimicrobial Agents and Chemotherapy.2018;[Epub]     CrossRef
  • Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species
    J. D. Sobel, R. Sobel
    Expert Opinion on Pharmacotherapy.2018; 19(9): 971.     CrossRef
  • CYP51 as drug targets for fungi and protozoan parasites: past, present and future
    Galina I. Lepesheva, Laura Friggeri, Michael R. Waterman
    Parasitology.2018; 145(14): 1820.     CrossRef
  • TLS dependent and independent functions of DNA polymerase eta (Polη/Rad30) from Pathogenic Yeast Candida albicans
    Kodavati Manohar, Doureradjou Peroumal, Narottam Acharya
    Molecular Microbiology.2018; 110(5): 707.     CrossRef
  • Potential effect of 2-isopropyl-5-methylphenol (thymol) alone and in combination with fluconazole against clinical isolates of Candida albicans, C. glabrata and C. krusei
    A. Sharifzadeh, A.R. Khosravi, H. Shokri, H. Shirzadi
    Journal de Mycologie Médicale.2018; 28(2): 294.     CrossRef
  • Fluconazole-Pyridoxine Bis-Triazolium Compounds with Potent Activity against Pathogenic Bacteria and Fungi Including Their Biofilm-Embedded Forms
    Marsel R. Garipov, Roman S. Pavelyev, Svetlana A. Lisovskaya, Elena V. Nikitina, Airat R. Kayumov, Alina E. Sabirova, Oksana V. Bondar, Albina G. Malanyeva, Alexander M. Aimaletdinov, Alfia G. Iksanova, Konstantin V. Balakin, Yurii G. Shtyrlin
    Journal of Chemistry.2017; 2017: 1.     CrossRef
  • Bridging the Gap to Non-toxic Fungal Control: Lupinus-Derived Blad-Containing Oligomer as a Novel Candidate to Combat Human Pathogenic Fungi
    Ana M. Pinheiro, Alexandra Carreira, Thomas A. K. Prescott, Ricardo B. Ferreira, Sara A. Monteiro
    Frontiers in Microbiology.2017;[Epub]     CrossRef
  • An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses
    Irene A. I. Hampe, Justin Friedman, Mira Edgerton, Joachim Morschhäuser, Julia Ruth Koehler
    PLOS Pathogens.2017; 13(9): e1006655.     CrossRef
  • Antimicrobial activity of Buchenavia tetraphylla against Candida albicans strains isolated from vaginal secretions
    José Robson Neves Cavalcanti Filho, Tiago Fonseca Silva, Woah Queiroz Nobre, Larissa Isabela Oliveira de Souza, Cristiane Santos Silva e Silva Figueiredo, Regina Celia Bressan Queiroz de Figueiredo, Norma Buarque de Gusmão, Márcia Vanusa Silva, Luís Cláud
    Pharmaceutical Biology.2017; 55(1): 1521.     CrossRef
  • Antifungal Resistance: An Emerging Reality and A Global Challenge
    Dimitrios P Kontoyiannis
    The Journal of Infectious Diseases.2017; 216(suppl_3): S431.     CrossRef
  • Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance
    Zhongle Liu, Lawrence C. Myers
    Antimicrobial Agents and Chemotherapy.2017;[Epub]     CrossRef
  • Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis
    Tatiana Y. Hargrove, Laura Friggeri, Zdzislaw Wawrzak, Aidong Qi, William J. Hoekstra, Robert J. Schotzinger, John D. York, F. Peter Guengerich, Galina I. Lepesheva
    Journal of Biological Chemistry.2017; 292(16): 6728.     CrossRef
  • The natural compound magnolol affects growth, biofilm formation, and ultrastructure of oral Candida isolates
    Jawad Behbehani, Sheikh Shreaz, Mohammad Irshad, Maribassapa Karched
    Microbial Pathogenesis.2017; 113: 209.     CrossRef
  • The Structure of Thymidylate Kinase from Candida albicans Reveals a Unique Structural Element
    Kaustubh Sinha, Gordon S. Rule
    Biochemistry.2017; 56(33): 4360.     CrossRef
  • Histone Acetyltransferase Encoded by NGG1 is Required for Morphological Conversion and Virulence of Candida Albicans
    De-Dong Li, Beth Burgwyn Fuchs, Yan Wang, Xiao-Wen Huang, Dan-Dan Hu, Yan Sun, Dong Chai, Yuan-Ying Jiang, Eleftherios Mylonakis
    Future Microbiology.2017; 12(16): 1497.     CrossRef
  • Human fungal pathogens: Why should we learn?
    Jeong-Yoon Kim
    Journal of Microbiology.2016; 54(3): 145.     CrossRef
  • Candidaspecies isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis ofCandida albicansandCandida glabratabiofilms
    Valentina Cataldi, Emanuela Di Campli, Paolo Fazii, Tonino Traini, Luigina Cellini, Mara Di Giulio
    Medical Mycology.2016; : myw126.     CrossRef

Journal of Microbiology : Journal of Microbiology
TOP